openPR Logo
Press release

Melanoma detection Market to Perceive Substantial Growth During 2017 - 2025

11-28-2017 02:57 PM CET | Health & Medicine

Press release from: Persistence Market Research

Melanoma detection Market to Perceive Substantial Growth

Melanoma is a type of skin cancer where melanocytes lose its ability of apoptosis. Melanoma can develop anywhere on the epidermis, but most probably it affects trunk and legs of the body. It is possible to treat melanoma if it is found early. So, it is of profound importance to diagnose melanoma as early as possible. In some cases, melanoma can easily diagnose by the physical appearance of skin. But in many cases, biopsy procedures are used for detection of melanoma. There are three types of biopsy procedures for melanoma detection namely: punch biopsy, excisional biopsy, and incisional biopsy. Basically, in punch biopsy, part of the skin around mole is removed and analyzed, but in case of excisional and incisional biopsy procedures whole skin around the mole is removed and analyzed. After melanoma detection, the next step is to find out the extent of the melanoma. It can be identified by determining the thickness of the melanoma and spreading coefficient of cancer. Thickness can be determined by microscopy and micrometer. Another method of melanoma detection includes fine needle aspiration, surgical lymph node biopsy, sentinel lymph node biopsy. Other techniques like x-ray, CT scan, magnetic resonance imaging scan, positron emission tomography scans are used to identify the spread of melanoma to other parts.

View Report Preview @ https://www.persistencemarketresearch.com/market-research/melanoma-detection-market.asp

Melanoma is less prevalent when compared to other skin cancers like squamous cell and basal cell cancers. But the severity is very high when compared to other skin cancers if melanoma is left undiagnosed in the early stages. So, it is the prime requisite for early detection of melanoma which drives the robust growth of the melanoma detection market. Other factors like, spreading of melanoma and admancement occur very rapidly to other parts of the body which increases the risk of mortality in melanoma patients. The increasing prevalence of melanoma due to changing environmental conditions and increasing demand for rapid diagnostics for early detection of melanoma is driving the burgeoning growth of the melanoma detection market.

Due to difficulties in accessing the histological diagnosis of melanocyte cutaneous lesions acts as a restraint in the growth of the melanoma detection market

Global Melanoma detection market witnessed rapid growth due to rising demand for non-invasive techniques for detection of melanoma. Even though the demand increasing for non-invasive techniques, histopathological detection acts as a golden standard for diagnosis of melanoma. The manufacturers of melanoma diagnostics are mainly concentrated on technological advancements to increase the reliability of the tests. Increasing government funding for improvement of rapid diagnostics and rising concerns of melanoma issues are driving the growth of the melanoma detection market. The future of Melanoma detection market is anticipated to grow at double CAGR during the forecast period.

Global melanoma detection market segmented into North America, Europe, Asia -Pacific & Japan, The Middle East and Africa regions and Latin America by region wise. North America dominates the global Melanoma detection Market due to the high prevalence among the patient population, and in North America, USA is a major stakeholder due to the strong players. Europe is the fastest growing market in Melanoma detection Market due to the strong presence of market players. Asia-Pacific is a slowest growing region in the global melanoma detection market due to less presence of the melanoma. Latin America has a significant market share due to rising prevalence of the melanoma. The economic conditions in Latin region rise the Melanoma detection market to new heights. The Middle East and Africa region also showed significantly less growth because the incidence of the melanoma in this region is considerably less.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/18970

The end users are major players like hospitals, clinics, and diagnostic centers are the major stakeholders in the global melanoma detection market. The companies are mainly focusing on intense marketing to convey health benefits of melanoma detection market.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Melanoma detection Market to Perceive Substantial Growth During 2017 - 2025 here

News-ID: 835864 • Views:

More Releases from Persistence Market Research

Cold Plasma Market to Reach US$8 Billion by 2032, Growing at 15.8% CAGR: Persistence Market Research
Cold Plasma Market to Reach US$8 Billion by 2032, Growing at 15.8% CAGR: Persist …
The global cold plasma market is on a robust growth trajectory, poised to expand from an estimated value of USD 2.9 billion in 2025 to approximately USD 8 billion by 2032. This significant growth represents a compound annual growth rate (CAGR) of 15.8% during the forecast period. This surge is primarily driven by the increasing adoption of cold plasma solutions across various sectors, including healthcare, food safety, and electronics manufacturing. Request
Ophthalmic Imaging Equipment Market Set to Reach US$3.4 Billion by 2032 at 4.9% CAGR
Ophthalmic Imaging Equipment Market Set to Reach US$3.4 Billion by 2032 at 4.9% …
The global ophthalmic imaging equipment market is poised for significant growth, driven by technological advancements, an aging population, and an increasing prevalence of eye diseases. According to Persistence Market Research, the market is expected to be valued at approximately USD 2.4 billion by 2025 and is projected to reach USD 3.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2025
Oral Irrigator Market to Reach US$2.4 Billion by 2032, Growing at 4.7% CAGR: Persistence Market Research
Oral Irrigator Market to Reach US$2.4 Billion by 2032, Growing at 4.7% CAGR: Per …
The global oral irrigator market is positioned for steady growth over the coming decade. The base reference point is that the global oral irrigator market size is likely to be valued at US $1.8 billion in 2025, expected to reach US $2.4 billion by 2032, growing at a CAGR of 4.7 % during the forecast period from 2025 to 2032. This projected expansion is underpinned by multiple demand drivers, evolving
U.S. Surgical Microscope Market Set to Reach US$915.1 Mn by 2032, Growing at 11.0% CAGR
U.S. Surgical Microscope Market Set to Reach US$915.1 Mn by 2032, Growing at 11. …
The U.S. surgical microscope market is poised for significant expansion over the coming years. According to recent market estimates, the U.S. surgical microscope market size is likely to be valued at US$ 440.8 million in 2025 and projected to reach US$ 915.1 million by 2032, growing at a compound annual growth rate (CAGR) of 11.0 % during the forecast period from 2025 to 2032. Request a Sample: https://www.persistencemarketresearch.com/samples/35723 This robust growth

All 5 Releases


More Releases for Melanoma

Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period? The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market? The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market? The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: • Pfizer Inc. • Bristol-Myers Squibb Company • Abbott Laboratories • Amgen, Inc. • Merck & Co., Inc. • Novartis AG • F. Hoffmann-La Roche Ltd • Sanofi S.A. • Qiagen NV • Sun Pharmaceutical Industries Ltd
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic